FBXW7 and prostate carcinoma: Previous studies [5,6] showed that the down-regulated expression of FBXW7 by 3D spheroid formation suppressed the protein degradation of KCa1.1 in human prostate cancer LNCaP cells, which increased KCa1.1 activity.